543 — Bowling Green, Kentucky

543 is a clinical research site located in Bowling Green, Kentucky, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

543 has participated in 1 clinical trials.

Therapeutic areas: Systemic Lupus Erythematosus.

Sponsors: UCB Pharma.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Bowling Green

Browse all research sites in Kentucky · View every site in Bowling Green

• TriStar Greenview Regional Hospital
• Greenview Regional Hospital
• Western Kentucky University
• Graves-Gilbert Clinic
• Equity Medical
• Research Site
• Equity Medical Bowling Green
• Qualmedica Research
• Novartis Investigative Site
• Medical Center at Bowling Green
• GSK Investigational Site
• Forest Investigative Site 2033

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 543?

543 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 543 conducted?

543 has 1 clinical trials on record. Their work covers Systemic Lupus Erythematosus.

Is 543 accredited by Crixeo Clinical Trials?

543 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 543?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.